Preview Mode Links will not work in preview mode

This Week in Cardiology

Oct 29, 2021

ESUS, CAC 0, Takotsubo syndrome, and chest pain are the topics John Mandrola, MD, covers in today’s podcast. To read a partial transcript or to comment, visit:


Anticoagulation May Benefit Stroke Patients With LV Dysfunction

- Left Ventricular Dysfunction Among Patients With Embolic Stroke of Undetermined Source and the Effect of Rivaroxaban vs AspirinA Subgroup Analysis of the NAVIGATE ESUS Randomized Clinical Trial

- Rivaroxaban for Stroke Prevention after Embolic Stroke of Undetermined Source

- Dabigatran for Prevention of Stroke after Embolic Stroke of Undetermined Source


CAC Score 0 Unreliable to Rule Out Stenosis in Younger Patients

- Association of Age With the Diagnostic Value of Coronary Artery Calcium Score for Ruling Out Coronary Stenosis in Symptomatic Patients

- The Case Against Coronary Artery Calcium Scoring for Cardiovascular Disease Risk Assessment

III – Takotsubo Cardiomyopathy

Broken Heart Syndrome: On the Rise, Especially in Women 50-74

- Sex‐ and Age‐Based Temporal Trends in Takotsubo Syndrome Incidence in the United States

IV- Chest Pain Guidelines

AHA/ACC Issues First Comprehensive Guidance on Chest Pain

- 2021 AHA/ACC/ASE/CHEST/SAEM/SCCT/SCMR Guideline for the Evaluation and Diagnosis of Chest Pain: Executive Summary: A Report of the American College of Cardiology/American Heart Association Joint Committee on Clinical Practice Guidelines

You may also like:

Medscape editor-in-chief Eric Topol, MD, and master storyteller and clinician Abraham Verghese, MD, on Medicine and the Machine

The Bob Harrington Show with Stanford University Chair of Medicine, Robert A. Harrington, MD.

Questions or feedback, please contact